Meet Drug Price Fighting Hero Ann Neilson
Besides her work stateside, Ann has flown to Washington, DC twice with Patients for Affordable Drugs to share her story with her federal legislators and demand a decrease in prescription drug prices.
Besides her work stateside, Ann has flown to Washington, DC twice with Patients for Affordable Drugs to share her story with her federal legislators and demand a decrease in prescription drug prices.
Patients For Affordable Drugs is happy to name Dennis Linthicum, a Republican state senator from Oregon, a December Drug Price Fighting Hero for his leadership in the fight to lower prescription drug prices.
Elizabeth Rowley has channeled her experiences as a person living with Type 1 diabetes into global activism for her community, founding the nonprofit T1International to help assure patients have access to life-sustaining insulin, supplies and medical care.
Yvanna Cancela is a state senator from Nevada and the lead sponsor of a first-in-the-nation insulin pricing transparency law to hold drugmakers and pharmacy benefit managers accountable for never-ending price spikes that hurt patients.
Andy has called out the pharmaceutical industry, noting that, despite massive corporate tax cuts, the drug industry has refused to lower prices.
Rebecca Hall lives with stage 4 metastatic breast cancer, a progressively disabling cancer. At 29 years old, Hall’s goals to advance her career and grow old with her husband evaporated when she received the results of a cancer scan.
Victoria Stuessel is 34- year-old wife and mother living with multiple sclerosis, a degenerative and progressively disabling disease of the Central Nervous System. Victoria is this month’s Price Fighting Hero for being a fierce patient advocate and an inspiration.
Under Scott Gottlieb’s leadership as the head of the Food and Drug Administration, the FDA has focused on bringing more generic drugs to market to compete with pricier name-brand drugs and help lower prescription drug prices.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.